BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) shares were down 4.3% during mid-day trading on Friday . The company traded as low as $0.44 and last traded at $0.47. Approximately 681,387 shares traded hands during trading, an increase of 545% from the average daily volume of 105,573 shares. The stock had previously closed at $0.49.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reduced their target price on shares of BiomX from $21.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, May 16th.
Read Our Latest Stock Analysis on PHGE
BiomX Trading Down 4.3%
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Stories
- Five stocks we like better than BiomX
- What Are the FAANG Stocks and Are They Good Investments?
- A Large Oil Supply Draw Could Mean Upside in These 3 Energy Names
- Differences Between Momentum Investing and Long Term Investing
- 3 Stocks Getting Rare Double Upgrades From Analysts
- Financial Services Stocks Investing
- This Banking Giant Just Got a $90 Price Target Upgrade
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
